As of May 22
| +0.44 / +0.49%|
The 4 analysts offering 12-month price forecasts for Ligand Pharmaceuticals Inc have a median target of 99.50, with a high estimate of 127.00 and a low estimate of 86.00. The median estimate represents a +10.96% increase from the last price of 89.67.
The current consensus among 4 polled investment analysts is to Buy stock in Ligand Pharmaceuticals Inc. This rating has held steady since May, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.